Latest ownership filings
4
Corvus Pharmaceuticals, Inc.
8 May 24
SC 13D/A
Corvus Pharmaceuticals, Inc.
8 May 24
4
NeuroPace Inc
3 May 24
4
NeuroPace Inc
26 Apr 24
4
NeuroPace Inc
23 Apr 24
4
NeuroPace Inc
18 Apr 24
4
NeuroPace Inc
15 Apr 24
SC 13D/A
Passage BIO, Inc.
12 Apr 24
3/A
Traws Pharma, Inc.
12 Apr 24
4
Kinnate Biopharma Inc.
5 Apr 24
SC 13D/A
Enliven Therapeutics, Inc.
4 Apr 24
3
Traws Pharma, Inc.
3 Apr 24
SC 13D
Q32 Bio Inc.
28 Mar 24
3
Q32 Bio Inc.
27 Mar 24
SC 13D/A
Compass Therapeutics, Inc.
22 Mar 24
SC 13D/A
Adicet Bio, Inc.
21 Mar 24
SC 13D/A
NextCure, Inc.
8 Mar 24
144
Verona Pharma plc
4 Mar 24
SC 13D/A
Kinnate Biopharma Inc.
21 Feb 24
SC 13G/A
ALX ONCOLOGY HOLDINGS INC
14 Feb 24
SC 13G
InspireMD, Inc.
14 Feb 24
SC 13G/A
X4 Pharmaceuticals, Inc
14 Feb 24
SC 13G/A
Verastem, Inc.
14 Feb 24
SC 13G/A
SI-BONE, Inc.
14 Feb 24
SC 13G
Scholar Rock Holding Corp
14 Feb 24
SC 13G/A
Protara Therapeutics, Inc.
14 Feb 24
SC 13G/A
NeuroPace Inc
14 Feb 24
SC 13G/A
Mersana Therapeutics, Inc.
14 Feb 24
SC 13G/A
Mereo BioPharma Group plc
14 Feb 24
SC 13G/A
Kezar Life Sciences, Inc.
14 Feb 24
SC 13G
Elevation Oncology, Inc.
14 Feb 24
SC 13G/A
Crinetics Pharmaceuticals, Inc.
14 Feb 24
SC 13G/A
Applied Therapeutics Inc.
14 Feb 24
13F-HR
Quarterly holdings report by institutional manager
14 Feb 24
4
Theseus Pharmaceuticals, Inc.
14 Feb 24
SC 13D/A
CalciMedica, Inc.
5 Feb 24
SC 13D
ArriVent Biopharma, Inc.
5 Feb 24
4
ArriVent Biopharma, Inc.
31 Jan 24
SC 13D/A
Adicet Bio, Inc.
29 Jan 24
4
Adicet Bio, Inc.
26 Jan 24